5 Key Takeaways

• 1

  Nearly half of pregnant women prescribed SSRIs or SNRIs discontinue their use during pregnancy.

• 2

  A study found no increase in adverse psychiatric outcomes postpartum for women who discontinued these medications.

• 3

  The study followed 27,773 Swedish women, with 47.5% stopping treatment during pregnancy.

• 4

  Psychiatric-related hospitalizations were low, occurring in 0.4% of the discontinued group and 0.5% of the continued-use group.

• 5

  Women who discontinued medication had fewer sick leave days on average compared to those who continued their treatment.